MRD / Regn No. : SG004647 Date : 06/07/2026
Patient Name : Gopal Kr Dutta Age & Gender : 58 Yrs. / Male
Contact No. : 7003038556 UHID :
Ht / Wt / BMI : 165 / 75 / 27.55 BP S / BP D : 119 / 73
Allergies : NKA Referred By :
   
Problem List : PTCA (06/Jul/2017) | TYPE 2 DIABETES (06/Jul/2000) |
Plan : CONTINUE OTHER MEDICINES BY CARDIOLOGIST  
Salient Investigations : CREATININE: 0.9 | EGFR EGLOMERULAR FILTRATION RATE: 92.34 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 107 mg/dL | HB HEMOGLOBIN: 12.8 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 9.1 % | LDL LOW DENSITY LIPOPROTEIN: 102 mg/dL | MICROALBUMIN CREATININE RATIO: 340 mcg/mg
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES 		SQ 0-0-30 BEDTIME
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
2 SEMAGLUTIDE 0.25 MG; 0.5 MG/DOSE)
OZEMPIC 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
3 GLICLAZIDE 80 MG + METFORMIN 500 MG
GLIZID M 		PO 1-0-1 BEFORE BREAKFAST AND DINNER
 TILL NEXT VISIT
4 EMPAGLIFLOZIN 10
GIBTULIO 		1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 06/Jan/2027
Tests Suggested For Next Visit : SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,CREATININE,LFT WITH PLATELET COUNT
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: